查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092967

2034年獸醫醫療治療計畫市場預測－按解決方案類型、部署方式、目標動物、治療類型、最終用戶和地區分類的全球分析

Veterinary Treatment Planning Market Forecasts to 2034 - Global Analysis By Solution Type, Deployment Mode, Animal Type, Treatment Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球獸醫治療計畫市場預計到 2026 年將達到 4 億美元，並在預測期內以 14.7% 的複合年成長率成長，到 2034 年將達到 12 億美元。

獸醫治療方案是一個系統化的過程，它根據臨床評估、診斷結果、病歷和治療目標，為每隻動物製定個人化的醫療策略。這包括選擇合適的治療方法、藥物、手術、復健方案和後續觀察方案，以應對特定的健康狀況。透過將實證獸醫實踐與患者的具體資訊結合，獸醫治療方案能夠支持準確的臨床決策，最佳化治療效果，加速患者康復，並促進有效的長期動物健康管理。

專業醫療照護日益複雜

隨著獸醫學的日益複雜化，對能夠指導獸醫遵循循證治療方案的系統化治療計劃解決方案的需求也日益成長。腫瘤科、神經科和整形外科病例需要結合手術、化療、放療和復健等多方面治療，而系統化的計劃工具在其中發揮著至關重要的作用。獸醫轉診醫院需要標準化的診療路徑，以確保輪轉住院醫師和專科醫生之間診療品質的一致性。全科獸醫也擴大遇到超出其訓練範圍的複雜病例，這導致對決策支援工具的需求不斷成長。將治療計劃整合到電子健康記錄中，能夠實現基於方案的診療流程的標準化。

客製化要求

獸醫治療方案的發展具有高度個人化的特點，這對標準化軟體解決方案構成了重大挑戰。每隻動物都擁有其獨特的物種、品種、年齡、體重、合併症以及飼主限制等因素，這使得模板化方案難以應用。獸醫專業人員需要高度客製化的功能，這增加了軟體的複雜性和實施成本。動物物種和疾病的多樣性遠遠超出了單一規劃資料庫的承載範圍。為了滿足這些客製化需求，需要靈活的平台架構和大量的配置投入。

腫瘤治療方案的標準化

獸醫腫瘤服務的擴展為治療計劃平台市場帶來了巨大的成長機會。化療製定、放射治療計畫和手術切除範圍，都需要藉助軟體系統進行精確協調。標準化的腫瘤治療方案能夠確保各治療中心在劑量、時間安排和監測方面的一致性，進而提高治療效果。由於飼主越來越希望為他們的伴侶動物治療癌症，目標市場正在不斷擴大。獸醫腫瘤專家和軟體開發人員之間的合作正在建立基於實證醫學的方案庫。

對獸醫自主權的擔憂

一些獸醫專業人員可能認為治療計劃軟體會削弱他們的臨床自主權和專業判斷。經驗豐富的獸醫如果擁有成熟的治療方法，可能會抵制基於方案的建議。對偏離系統生成計畫可能承擔法律責任的擔憂，造成了法律上的不確定性。在簡單的病例中，輸入病例資料和審查系統建議所需的時間可能超過其帶來的效率提升。鑑於這些專業和文化方面的挑戰，治療計劃需要被定位為“決策支援”，而不是“指示”。

新冠疫情的影響：

新冠疫情加速了獸醫學中治療計劃的普及，因為它要求遠距醫療建立系統化的記錄和清晰的護理流程。遠端醫療提供者利用治療計劃範本來確保遠距醫療品質的一致性。然而，擇期手術的延遲暫時減少了手術計劃系統的使用。疫情後，混合醫療模式的建立和專科獸醫學的持續發展正在推動對治療計劃基礎設施的持續投資。

在預測期內，治療計劃軟體領域預計將佔據最大的市場佔有率。

預計在預測期內，治療計劃軟體領域將佔據最大的市場佔有率，因為它在所有獸醫專科的治療決策系統中發揮著至關重要的作用。治療計畫軟體提供範本、計算工具和決策樹，幫助獸醫妥善管理診斷測試、治療方案和後續觀察計畫。這些平台整合了藥物資料庫、劑量計算器和藥物交互作用檢查器，以減少用藥錯誤。獸醫處方箋記錄方面日益嚴格的監管要求正在推動結構化計劃系統的應用。領先的獸醫軟體供應商正在將治療計劃模組整合到綜合臨床管理平台中。

預計在預測期內，基於人工智慧的治療推薦平台細分市場將實現最高的複合年成長率。

在預測期內，「基於人工智慧的治療推薦平台」細分市場預計將呈現最高的成長率，這主要得益於機器學習技術在大規模獸醫診療結果資料集中的模式識別方面的進步。人工智慧演算法透過分析相似病例、治療反應和併發症發生率，產生個人化的建議排名。這項技術能夠減少不同獸醫和醫療機構在診斷和治療上的差異。基於雲端的部署將使全科診所無需專家會診即可使用先進的推薦引擎。科技公司與獸醫教學醫院之間的合作研究正在不斷擴展訓練資料集並檢驗演算法的準確性。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其先進的獸醫專科醫療基礎設施以及對臨床決策支援技術的早期應用。美國憑藉其龐大的獸醫專科醫院和學術機構網路引領市場，這些機構能夠產生循證規劃工具所需的臨床數據。加拿大則透過先進的獸醫教育和資金充足的研究計畫做出貢獻。寵物飼主對專科醫療保健的投入意願也推動了對先進治療方案的需求。 IDEXX Laboratories、Zoetis 和 Mars Science & Diagnostics 等領先企業在全部區域保持顯著的市場佔有率。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於獸醫專科醫療服務的快速擴張和臨床實踐專業化程度的不斷提高。中國和日本是關鍵的成長市場，兩國在獸醫腫瘤學、心臟病學和神經病學等領域的投資不斷增加。澳洲和韓國擁有較高的技術應用率和先進的診斷能力。循證獸醫學的日益普及正在推動系統化治療方案的採用。該地區蓬勃發展的軟體開發產業也為本地平台開發提供了支援。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性評估）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰和機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球獸醫治療計劃市場：按解決方案類型分類

  • 治療計畫軟體
  • 臨床決策支援系統
  • 護理路徑管理平台
  • 處方管理解決方案
  • 治療計劃系統
  • 人工智慧驅動的治療推薦平台
  • 整合臨床工作流程解決方案

第6章：全球獸醫醫療治療計畫市場：依部署模式分類

  • 基於雲端的
  • 現場
  • 混合實現
  • 網路為基礎的平台

第7章：全球獸醫醫療治療計畫市場：依動物類型分類

  • 伴侶動物
  • 家畜
  • 馬
  • 異域動物
  • 水生動物
  • 野生動物

第8章：全球獸醫醫療治療計劃市場：按治療類型分類

  • 藥物治療
  • 手術治療方案
  • 復健計劃
  • 腫瘤治療方案
  • 預防保健計劃
  • 慢性病管理

第9章：全球獸醫治療計劃市場：按最終用戶分類

  • 動物醫院
  • 動物診所
  • 診斷檢查室
  • 學術機構
  • 研究機構
  • 遠端醫療提供者

第10章：全球獸醫治療計畫市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • IDEXX Laboratories, Inc
  • Covetrus, Inc.
  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • ezyVet Limited
  • NaVetor
  • Heska Corporation
  • Antech Diagnostics
  • Mars Science & Diagnostics
  • Ceva Sante Animale
  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Animal Intelligence Software Inc.
  • SignalPET
Product Code: SMRC38136

According to Stratistics MRC, the Global Veterinary Treatment Planning Market is accounted for $0.4 billion in 2026 and is expected to reach $1.2 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Veterinary Treatment Planning refers to the systematic process of developing individualized medical care strategies for animals based on clinical evaluation, diagnostic findings, medical history, and therapeutic objectives. It involves selecting appropriate treatments, medications, surgical interventions, rehabilitation protocols, and follow-up care to address specific health conditions. By integrating evidence-based veterinary practices and patient-specific information, veterinary treatment planning supports accurate clinical decision-making, optimizes treatment outcomes, enhances patient recovery, and promotes effective long-term animal health management.

Market Dynamics:

Driver:

Specialty care complexity

The increasing complexity of veterinary specialty care is driving substantial demand for structured treatment planning solutions that guide practitioners through evidence-based therapeutic protocols. Oncology, neurology, and orthopedic cases require multi-modal treatment sequences involving surgery, chemotherapy, radiation, and rehabilitation that benefit from systematic planning tools. Veterinary referral hospitals require standardized care pathways that ensure consistent quality across rotating residents and specialists. End-user general practitioners increasingly encounter complex cases that exceed their training, creating demand for decision support tools. The integration of treatment planning into electronic medical records normalizes protocol-driven care.

Restraint:

Customization requirements

The highly individualized nature of veterinary treatment planning presents significant challenges for standardized software solutions. Each animal presents unique combinations of species, breed, age, weight, comorbidities, and owner constraints that resist templated protocol application. Veterinary professionals require extensive customization capabilities that increase software complexity and implementation costs. The diversity of veterinary species and conditions exceeds the scope of any single planning database. These customization demands necessitate flexible platform architectures and substantial configuration investments.

Opportunity:

Oncology protocol standardization

The expansion of veterinary oncology services presents transformative market expansion opportunities for treatment planning platforms. Cancer treatment protocols involving chemotherapy scheduling, radiation planning, and surgical margins require precise coordination that software systems facilitate. Standardized oncology protocols improve outcomes through consistent dosing, timing, and monitoring across treatment centers. Growing pet owner willingness to pursue cancer treatment for companion animals expands the addressable market. Partnerships between veterinary oncology specialists and software developers create evidence-based protocol libraries.

Threat:

Practitioner autonomy concerns

Veterinary professionals may perceive treatment planning software as undermining their clinical autonomy and professional judgment. Experienced practitioners with established therapeutic approaches may resist protocol-driven recommendations. Liability concerns when deviating from system-generated plans create legal uncertainty. The time required to input case data and review system recommendations may exceed the efficiency benefits for straightforward cases. These professional culture challenges necessitate positioning treatment planning as decision support rather than directive.

Covid-19 Impact:

The COVID-19 pandemic accelerated veterinary treatment planning adoption as remote consultations required structured documentation and clear care protocols. Telemedicine providers relied on treatment planning templates to ensure consistent virtual care quality. However, deferred elective procedures temporarily reduced surgical planning system utilization. Post-pandemic, the normalization of hybrid care models and continued specialty care growth support sustained investment in treatment planning infrastructure.

The Treatment Planning Software segment is expected to be the largest during the forecast period

The Treatment Planning Software segment is expected to account for the largest market share during the forecast period, due to its foundational role in structuring therapeutic decisions across all veterinary specialties. Treatment planning software provides templates, calculators, and decision trees that guide practitioners through diagnostic workup, therapeutic options, and monitoring schedules. The platforms integrate drug databases, dosing calculators, and interaction checkers that reduce medication errors. Growing regulatory requirements for veterinary prescription documentation drive the adoption of structured planning systems. Major veterinary software vendors embed treatment planning modules into comprehensive practice management platforms.

The AI-Based Treatment Recommendation Platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-Based Treatment Recommendation Platforms segment is predicted to witness the highest growth rate, driven by advances in machine learning for pattern recognition across large veterinary outcome datasets. Artificial intelligence algorithms analyze similar cases, treatment responses, and complication rates to generate personalized recommendation rankings. The technology reduces diagnostic and therapeutic variability between practitioners and institutions. Cloud-based deployment makes advanced recommendation engines accessible to general practices without specialist consultation. Research partnerships between technology companies and veterinary teaching hospitals continuously expand training datasets and validate algorithm accuracy.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced veterinary specialty infrastructure and early adoption of clinical decision support technologies. The United States leads with extensive networks of veterinary specialty hospitals and academic institutions that generate the clinical data required for evidence-based planning tools. Canada contributes through its progressive veterinary education and well-funded research programs. High pet owner willingness to invest in specialty care drives demand for sophisticated treatment planning. Major companies, including IDEXX Laboratories, Zoetis, and Mars Science & Diagnostics, maintain significant market presence across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding veterinary specialty services and increasing professionalization of clinical practice. China and Japan represent major growth markets with growing investment in veterinary oncology, cardiology, and neurology specialties. Australia and South Korea demonstrate high technology adoption rates and advanced diagnostic capabilities. Growing awareness of evidence-based veterinary medicine supports the adoption of structured treatment planning. The region's expanding software development sector provides indigenous platform development capabilities.

Key players in the market

Some of the key players in Veterinary Treatment Planning Market include IDEXX Laboratories, Inc., Covetrus, Inc., Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, ezyVet Limited, NaVetor, Heska Corporation, Antech Diagnostics, Mars Science & Diagnostics, Ceva Sante Animale, Virbac S.A., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Animal Intelligence Software Inc. and SignalPET.

Key Developments:

In June 2026, Virbac S.A. launched an artificial intelligence-powered oncology treatment planning platform analyzing tumor characteristics and patient history to generate personalized chemotherapy and radiation protocols.

In May 2026, Elanco Animal Health Incorporated secured a major contract deploying care pathway management platforms across European veterinary specialty hospital networks for standardized chronic disease management protocols.

In April 2026, ezyVet Limited introduced a next-generation surgical planning solution integrating three-dimensional imaging with augmented reality visualization for precise orthopedic procedure planning in companion animals.

Solution Types Covered:

  • Treatment Planning Software
  • Clinical Decision Support Systems
  • Care Pathway Management Platforms
  • Prescription Management Solutions
  • Therapy Planning Systems
  • AI-Based Treatment Recommendation Platforms
  • Integrated Clinical Workflow Solutions

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises
  • Hybrid Deployment
  • Web-Based Platforms

Animal Types Covered:

  • Companion Animals
  • Livestock
  • Equine
  • Exotic Animals
  • Aquatic Animals
  • Wildlife

Treatment Types Covered:

  • Medical Therapy
  • Surgical Planning
  • Rehabilitation Planning
  • Oncology Treatment Planning
  • Preventive Care Planning
  • Chronic Disease Management

End Users Covered:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Diagnostic Laboratories
  • Academic Institutions
  • Research Organizations
  • Telemedicine Providers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Treatment Planning Market, By Solution Type

  • 5.1 Treatment Planning Software
  • 5.2 Clinical Decision Support Systems
  • 5.3 Care Pathway Management Platforms
  • 5.4 Prescription Management Solutions
  • 5.5 Therapy Planning Systems
  • 5.6 AI-Based Treatment Recommendation Platforms
  • 5.7 Integrated Clinical Workflow Solutions

6 Global Veterinary Treatment Planning Market, By Deployment Mode

  • 6.1 Cloud-Based
  • 6.2 On-Premises
  • 6.3 Hybrid Deployment
  • 6.4 Web-Based Platforms

7 Global Veterinary Treatment Planning Market, By Animal Type

  • 7.1 Companion Animals
  • 7.2 Livestock
  • 7.3 Equine
  • 7.4 Exotic Animals
  • 7.5 Aquatic Animals
  • 7.6 Wildlife

8 Global Veterinary Treatment Planning Market, By Treatment Type

  • 8.1 Medical Therapy
  • 8.2 Surgical Planning
  • 8.3 Rehabilitation Planning
  • 8.4 Oncology Treatment Planning
  • 8.5 Preventive Care Planning
  • 8.6 Chronic Disease Management

9 Global Veterinary Treatment Planning Market, By End User

  • 9.1 Veterinary Hospitals
  • 9.2 Veterinary Clinics
  • 9.3 Diagnostic Laboratories
  • 9.4 Academic Institutions
  • 9.5 Research Organizations
  • 9.6 Telemedicine Providers

10 Global Veterinary Treatment Planning Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 IDEXX Laboratories, Inc
  • 13.2 Covetrus, Inc.
  • 13.3 Zoetis Inc.
  • 13.4 Merck Animal Health
  • 13.5 Boehringer Ingelheim Animal Health
  • 13.6 ezyVet Limited
  • 13.7 NaVetor
  • 13.8 Heska Corporation
  • 13.9 Antech Diagnostics
  • 13.10 Mars Science & Diagnostics
  • 13.11 Ceva Sante Animale
  • 13.12 Virbac S.A.
  • 13.13 Dechra Pharmaceuticals PLC
  • 13.14 Elanco Animal Health Incorporated
  • 13.15 Animal Intelligence Software Inc.
  • 13.16 SignalPET

List of Tables

  • Table 1 Global Veterinary Treatment Planning Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Veterinary Treatment Planning Market Outlook, By Solution Type (2023-2034) ($MN)
  • Table 3 Global Veterinary Treatment Planning Market Outlook, By Treatment Planning Software (2023-2034) ($MN)
  • Table 4 Global Veterinary Treatment Planning Market Outlook, By Clinical Decision Support Systems (2023-2034) ($MN)
  • Table 5 Global Veterinary Treatment Planning Market Outlook, By Care Pathway Management Platforms (2023-2034) ($MN)
  • Table 6 Global Veterinary Treatment Planning Market Outlook, By Prescription Management Solutions (2023-2034) ($MN)
  • Table 7 Global Veterinary Treatment Planning Market Outlook, By Therapy Planning Systems (2023-2034) ($MN)
  • Table 8 Global Veterinary Treatment Planning Market Outlook, By AI-Based Treatment Recommendation Platforms (2023-2034) ($MN)
  • Table 9 Global Veterinary Treatment Planning Market Outlook, By Integrated Clinical Workflow Solutions (2023-2034) ($MN)
  • Table 10 Global Veterinary Treatment Planning Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 11 Global Veterinary Treatment Planning Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 12 Global Veterinary Treatment Planning Market Outlook, By On-Premises (2023-2034) ($MN)
  • Table 13 Global Veterinary Treatment Planning Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
  • Table 14 Global Veterinary Treatment Planning Market Outlook, By Web-Based Platforms (2023-2034) ($MN)
  • Table 15 Global Veterinary Treatment Planning Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 16 Global Veterinary Treatment Planning Market Outlook, By Companion Animals (2023-2034) ($MN)
  • Table 17 Global Veterinary Treatment Planning Market Outlook, By Livestock (2023-2034) ($MN)
  • Table 18 Global Veterinary Treatment Planning Market Outlook, By Equine (2023-2034) ($MN)
  • Table 19 Global Veterinary Treatment Planning Market Outlook, By Exotic Animals (2023-2034) ($MN)
  • Table 20 Global Veterinary Treatment Planning Market Outlook, By Aquatic Animals (2023-2034) ($MN)
  • Table 21 Global Veterinary Treatment Planning Market Outlook, By Wildlife (2023-2034) ($MN)
  • Table 22 Global Veterinary Treatment Planning Market Outlook, By Treatment Type (2023-2034) ($MN)
  • Table 23 Global Veterinary Treatment Planning Market Outlook, By Medical Therapy (2023-2034) ($MN)
  • Table 24 Global Veterinary Treatment Planning Market Outlook, By Surgical Planning (2023-2034) ($MN)
  • Table 25 Global Veterinary Treatment Planning Market Outlook, By Rehabilitation Planning (2023-2034) ($MN)
  • Table 26 Global Veterinary Treatment Planning Market Outlook, By Oncology Treatment Planning (2023-2034) ($MN)
  • Table 27 Global Veterinary Treatment Planning Market Outlook, By Preventive Care Planning (2023-2034) ($MN)
  • Table 28 Global Veterinary Treatment Planning Market Outlook, By Chronic Disease Management (2023-2034) ($MN)
  • Table 29 Global Veterinary Treatment Planning Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Veterinary Treatment Planning Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
  • Table 31 Global Veterinary Treatment Planning Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
  • Table 32 Global Veterinary Treatment Planning Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 33 Global Veterinary Treatment Planning Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 34 Global Veterinary Treatment Planning Market Outlook, By Research Organizations (2023-2034) ($MN)
  • Table 35 Global Veterinary Treatment Planning Market Outlook, By Telemedicine Providers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.